Ekso Historical Balance Sheet

EKSO Stock

USD 0.43 0.02 4.44%

Trend analysis of Ekso Bionics Holdings balance sheet accounts such as Other Current Liabilities of 2.3 M or Total Current Liabilities of 6.7 M provides information on Ekso Bionics' total assets, liabilities, and equity, which is the actual value of Ekso Bionics Holdings to its prevalent stockholders. By breaking down trends over time using Ekso Bionics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Ekso Bionics Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ekso Bionics Holdings is a good buy for the upcoming year.

Ekso Bionics Inventory

3.11 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Ekso Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Ekso Bionics Holdings at a specified time, usually calculated after every quarter, six months, or one year. Ekso Bionics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ekso Bionics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ekso currently owns. An asset can also be divided into two categories, current and non-current.

Ekso Bionics Balance Sheet Chart

At this time, Ekso Bionics' Accounts Payable is very stable compared to the past year. As of the 27th of March 2025, Non Currrent Assets Other is likely to grow to about 489.9 K, while Total Assets are likely to drop about 26.2 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Ekso Bionics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ekso Bionics Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Ekso Bionics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ekso Bionics Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Ekso Bionics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Ekso Bionics Holdings current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	7.5M	7.2M	6.0M	5.1M
Total Assets	40.9M	28.9M	26.7M	26.2M

Short Long Term Debt Total Total Assets

Ekso Bionics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Common Stock Shares Outstanding	Other Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt
Total Assets		0.55	0.73	0.83	0.9	-0.77	-0.72	0.89	0.89	0.31	0.61	0.77	0.98	0.43	0.37	0.37	0.79	-0.03	0.09	0.19	-0.55	0.73	0.18	-0.55	-0.56	0.36
Short Long Term Debt Total	0.55		0.62	0.71	0.19	-0.13	-0.68	0.31	0.31	0.15	0.9	0.88	0.47	0.44	0.19	0.28	0.67	0.28	-0.56	0.43	-0.53	0.61	0.33	-0.54	-0.48	0.74
Other Current Liab	0.73	0.62		0.89	0.48	-0.37	-0.67	0.56	0.56	0.37	0.64	0.81	0.69	0.5	0.43	0.2	0.68	-0.17	-0.34	0.23	-0.71	0.67	0.05	-0.7	-0.72	0.54
Total Current Liabilities	0.83	0.71	0.89		0.56	-0.42	-0.79	0.59	0.59	0.49	0.7	0.9	0.77	0.69	0.55	0.31	0.81	-0.02	-0.34	0.41	-0.63	0.81	0.24	-0.64	-0.67	0.4
Total Stockholder Equity	0.9	0.19	0.48	0.56		-0.81	-0.54	0.88	0.88	0.12	0.23	0.41	0.92	0.29	0.17	0.38	0.62	-0.25	0.48	0.03	-0.41	0.56	0.1	-0.41	-0.44	0.15
Net Debt	-0.77	-0.13	-0.37	-0.42	-0.81		0.19	-0.97	-0.97	-0.41	-0.33	-0.41	-0.84	0.04	-0.39	0.13	-0.31	-0.23	-0.29	0.29	0.18	-0.44	0.26	0.14	0.09	-0.02
Retained Earnings	-0.72	-0.68	-0.67	-0.79	-0.54	0.19		-0.39	-0.39	0.04	-0.57	-0.72	-0.66	-0.68	-0.07	-0.76	-0.98	0.28	0.15	-0.34	0.76	-0.68	-0.28	0.82	0.84	-0.61
Cash	0.89	0.31	0.56	0.59	0.88	-0.97	-0.39		1.0	0.36	0.44	0.56	0.94	0.15	0.36	0.01	0.5	0.11	0.21	-0.14	-0.4	0.58	-0.17	-0.36	-0.32	0.21
Cash And Short Term Investments	0.89	0.31	0.56	0.59	0.88	-0.97	-0.39	1.0		0.36	0.44	0.56	0.94	0.15	0.36	0.01	0.5	0.11	0.21	-0.14	-0.4	0.58	-0.17	-0.36	-0.32	0.21
Common Stock Total Equity	0.31	0.15	0.37	0.49	0.12	-0.41	0.04	0.36	0.36		0.38	0.47	0.31	0.15	0.99	-0.46	0.0	0.52	-0.4	0.07	0.14	0.2	-0.12	0.16	0.16	-0.3
Non Current Liabilities Total	0.61	0.9	0.64	0.7	0.23	-0.33	-0.57	0.44	0.44	0.38		0.94	0.55	0.21	0.42	0.13	0.56	0.5	-0.59	0.27	-0.4	0.54	0.18	-0.39	-0.35	0.59
Total Liab	0.77	0.88	0.81	0.9	0.41	-0.41	-0.72	0.56	0.56	0.47	0.94		0.7	0.46	0.52	0.22	0.73	0.29	-0.52	0.36	-0.54	0.72	0.22	-0.55	-0.53	0.54
Total Current Assets	0.98	0.47	0.69	0.77	0.92	-0.84	-0.66	0.94	0.94	0.31	0.55	0.7		0.36	0.36	0.3	0.73	-0.02	0.14	0.04	-0.55	0.71	0.01	-0.54	-0.54	0.33
Short Term Debt	0.43	0.44	0.5	0.69	0.29	0.04	-0.68	0.15	0.15	0.15	0.21	0.46	0.36		0.2	0.39	0.68	-0.38	-0.23	0.62	-0.65	0.6	0.3	-0.7	-0.73	0.25
Common Stock	0.37	0.19	0.43	0.55	0.17	-0.39	-0.07	0.36	0.36	0.99	0.42	0.52	0.36	0.2		-0.32	0.09	0.46	-0.39	0.12	0.1	0.25	-0.06	0.11	0.09	-0.27
Common Stock Shares Outstanding	0.37	0.28	0.2	0.31	0.38	0.13	-0.76	0.01	0.01	-0.46	0.13	0.22	0.3	0.39	-0.32		0.69	-0.5	0.24	0.27	-0.41	0.33	0.45	-0.48	-0.57	0.33
Other Stockholder Equity	0.79	0.67	0.68	0.81	0.62	-0.31	-0.98	0.5	0.5	0.0	0.56	0.73	0.73	0.68	0.09	0.69		-0.26	-0.09	0.31	-0.76	0.69	0.27	-0.82	-0.83	0.59
Other Liab	-0.03	0.28	-0.17	-0.02	-0.25	-0.23	0.28	0.11	0.11	0.52	0.5	0.29	-0.02	-0.38	0.46	-0.5	-0.26		-0.44	-0.13	0.43	-0.01	-0.12	0.45	0.54	-0.15
Net Tangible Assets	0.09	-0.56	-0.34	-0.34	0.48	-0.29	0.15	0.21	0.21	-0.4	-0.59	-0.52	0.14	-0.23	-0.39	0.24	-0.09	-0.44		-0.31	0.24	-0.2	0.06	0.21	0.13	-0.37
Property Plant And Equipment Net	0.19	0.43	0.23	0.41	0.03	0.29	-0.34	-0.14	-0.14	0.07	0.27	0.36	0.04	0.62	0.12	0.27	0.31	-0.13	-0.31		-0.2	0.32	0.79	-0.2	-0.28	0.12
Current Deferred Revenue	-0.55	-0.53	-0.71	-0.63	-0.41	0.18	0.76	-0.4	-0.4	0.14	-0.4	-0.54	-0.55	-0.65	0.1	-0.41	-0.76	0.43	0.24	-0.2		-0.65	0.12	0.98	0.95	-0.71
Accounts Payable	0.73	0.61	0.67	0.81	0.56	-0.44	-0.68	0.58	0.58	0.2	0.54	0.72	0.71	0.6	0.25	0.33	0.69	-0.01	-0.2	0.32	-0.65		0.12	-0.61	-0.63	0.3
Non Current Assets Total	0.18	0.33	0.05	0.24	0.1	0.26	-0.28	-0.17	-0.17	-0.12	0.18	0.22	0.01	0.3	-0.06	0.45	0.27	-0.12	0.06	0.79	0.12	0.12		0.06	-0.05	0.02
Non Currrent Assets Other	-0.55	-0.54	-0.7	-0.64	-0.41	0.14	0.82	-0.36	-0.36	0.16	-0.39	-0.55	-0.54	-0.7	0.11	-0.48	-0.82	0.45	0.21	-0.2	0.98	-0.61	0.06		0.98	-0.71
Other Assets	-0.56	-0.48	-0.72	-0.67	-0.44	0.09	0.84	-0.32	-0.32	0.16	-0.35	-0.53	-0.54	-0.73	0.09	-0.57	-0.83	0.54	0.13	-0.28	0.95	-0.63	-0.05	0.98		-0.62
Long Term Debt	0.36	0.74	0.54	0.4	0.15	-0.02	-0.61	0.21	0.21	-0.3	0.59	0.54	0.33	0.25	-0.27	0.33	0.59	-0.15	-0.37	0.12	-0.71	0.3	0.02	-0.71	-0.62

Click cells to compare fundamentals

Ekso Bionics Account Relationship Matchups

Ekso Bionics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	20.6M	49.2M	40.9M	28.9M	26.7M	26.2M
Short Long Term Debt Total	9.7M	2.2M	7.5M	7.2M	6.0M	5.1M
Other Current Liab	1.4M	2.1M	2.0M	2.7M	2.4M	2.3M
Total Current Liabilities	5.0M	6.9M	9.2M	8.1M	7.5M	6.7M
Total Stockholder Equity	4.4M	37.2M	25.4M	12.6M	12.7M	13.7M
Net Debt	(9.0M)	(38.2M)	(13.0M)	(1.5M)	(510K)	(535.5K)
Retained Earnings	(199.1M)	(208.9M)	(223.9M)	(239.1M)	(250.5M)	(238.0M)
Cash	12.9M	40.4M	20.5M	8.6M	6.5M	6.2M
Cash And Short Term Investments	12.9M	40.4M	20.5M	8.6M	6.5M	6.2M
Liabilities And Stockholders Equity	20.6M	49.2M	40.9M	28.9M	26.7M	26.2M
Non Current Liabilities Total	11.2M	5.1M	6.3M	8.2M	6.4M	7.4M
Total Liab	16.2M	11.9M	15.5M	16.3M	13.9M	13.6M
Total Current Assets	18.4M	47.8M	31.0M	20.2M	18.8M	22.0M
Short Term Debt	548K	458K	3.0M	1.6M	1.7M	1.2M
Common Stock	63K	87K	8K	13K	15K	32.1K
Common Stock Shares Outstanding	7.2M	12.3M	13.0M	13.9M	20.2M	21.2M
Other Stockholder Equity	204.4M	246.1M	248.8M	251.6M	262.2M	188.7M
Other Liab	6.2M	7.9M	3.1M	1.4M	1.3M	1.2M
Net Tangible Assets	6.6M	4.4M	37.2M	19.8M	22.8M	15.5M
Property Plant And Equipment Net	2.7M	1.9M	1.2M	4.0M	3.0M	2.7M
Current Deferred Revenue	1.5M	1.2M	1.1M	2.0M	2.0M	1.4M
Accounts Payable	1.5M	3.1M	3.2M	1.8M	1.6M	2.4M
Non Current Assets Total	2.2M	1.4M	9.9M	8.7M	7.8M	5.4M
Non Currrent Assets Other	320K	164K	231K	392K	433K	489.9K
Other Assets	134K	178K	1.0M	164K	147.6K	140.2K
Long Term Debt	9.1M	2.0M	3.8M	4.8M	3.9M	3.8M
Net Receivables	3.4M	4.7M	4.6M	5.6M	7.2M	4.3M
Inventory	2.0M	2.2M	5.2M	5.1M	4.6M	3.1M
Other Current Assets	191K	970K	700K	875K	541K	646.1K
Property Plant And Equipment Gross	1.9M	1.2M	4.0M	6.2M	5.7M	3.3M
Accumulated Other Comprehensive Income	(847K)	(17K)	563K	156K	957K	1.0M
Property Plant Equipment	2.7M	1.2M	1.2M	4.0M	4.6M	2.6M

Pair Trading with Ekso Bionics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ekso Stock

0.77	HOLX	Hologic	Pair Corr
0.76	INFU	InfuSystems Holdings	Pair Corr

Moving against Ekso Stock

0.81	OCX	OncoCyte Corp	Pair Corr
0.7	LUCD	Lucid Diagnostics	Pair Corr
0.63	MNDR	Mobile health Network	Pair Corr
0.6	GOSS	Gossamer Bio	Pair Corr
0.38	PAVM	PAVmed Inc	Pair Corr

The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.

The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:

How To Invest In Ekso

Details

Is Ekso Stock a good investment?

Details

What is Ekso Bionics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.56)

Revenue Per Share

0.889

Quarterly Revenue Growth

0.05

Return On Assets

(0.24)

Return On Equity

(0.90)

The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ekso Historical Balance Sheet

Ekso Bionics Inventory

3.11 Million

About Ekso Balance Sheet Analysis

Ekso Bionics Balance Sheet Chart

Total Assets

Total Current Liabilities

Ekso Bionics balance sheet Correlations

Ekso Bionics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ekso Bionics balance sheet Accounts

Pair Trading with Ekso Bionics

Moving together with Ekso Stock

Moving against Ekso Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 0.99	Common Stock Total Equity
Total Current Assets	+ 0.98	Total Assets
Non Currrent Assets Other	+ 0.98	Current Deferred Revenue
Other Assets	+ 0.98	Non Currrent Assets Other
Other Assets	+ 0.95	Current Deferred Revenue

Other Stockholder Equity	- 0.98	Retained Earnings
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Total Current Assets	- 0.84	Net Debt
Other Assets	- 0.83	Other Stockholder Equity
Non Currrent Assets Other	- 0.82	Other Stockholder Equity